IEO to have a new Scientific Director at the end of the year when Prof Umberto Veronesi hands over the role to Prof Roberto Orecchia

Benefits of investing in skin cancer prevention

Tackling inequality in access to cancer care and information

Investigating anticarcinogenic compounds as an alternative to chemo

New rules for clinical trials

ecancermedicalscience Editor's Choice for May 2014

Upcoming trends in myeloma therapy

Lecture: PSA Screening - Where East meets West

Lecture: Current use of systemic therapies in localised disease

Use of GA101 and Clb preferable to rituximab in elderly or unfit chronic lymphocytic leukaemia patients

WIN Symposium 2014: Breakthrough biomarker investigations and combination therapies

Work and history of the Kidney Cancer Association